India  

Covid vaccine should be available for public by April 2021: Serum Institute CEO

IndiaTimes Friday, 20 November 2020
Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford Covid-19 vaccine should be available for healthcare workers and elderly people by around February 2021 and by April for the general public, and will be priced at a maximum of Rs 1,000 for two necessary doses for the public, depending on the final trial results and regulatory approvals.
0
shares
ShareTweetSavePostSend
 
Video Credit: HT Digital Content - Published
News video: Covid, vaccine race & what we don't know yet | Dr Guleria & Dr Jha #HTLS2020

Covid, vaccine race & what we don't know yet | Dr Guleria & Dr Jha #HTLS2020 32:54

The opening session of the 18th edition of the Hindustan Times Leadership Summit saw an enlightening discussion on the Covid-19 pandemic. Dr Ashish K. Jha, Dean, Brown University School of Public Health, and Dr Randeep Guleria, Director, All India Institute of Medical Sciences spoke on the race for a...

You Might Like


💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Disease caused by severe acute respiratory syndrome coronavirus 2

Study: Covid deaths have affected 82% of elderly with anxiety

Loneliness and a deepening sense of uncertainty has hit the senior citizens like never before during the second wave of Covid-19 pandemic, according to the..
IndiaTimes

Tauktae now ‘very severe’ cyclone, set to rip into Gujarat at 185kmph

Covid-bruised Gujarat braced for a battering by the strongest cyclone to hit its coast since 1998 as Tauktae, which cut a swathe through the western coastal belt..
IndiaTimes

‘PM Cares helped triple number of ventilators’

Ventilators allocated to states and Union Territories under PM Cares and the health ministry have more than tripled availability of the critical care machines in..
IndiaTimes

Beat 1st wave, halted 2nd, ready to face 3rd: Yogi Adityanath

Uttar Pradesh CM Yogi Adityanath asserted here on Sunday that the country’s largest state was able to arrest the second surge of Covid-19 and was prepared to..
IndiaTimes

Serum Institute of India Serum Institute of India Indian biotechnology and pharmaceuticals company

Govt rejects SII plea to export 50 lakh doses of Covishield to UK

Despite the international pressure and several rounds of negotiations by Serum Institute of India (SII), the government has turned down the request from SII to..
IndiaTimes

At Rs 700-Rs 1,500, price of Covid vaccine in India’s private sector among costliest

From Rs 250, the cost of vaccines in the private sector has shot up by up to six times. It now ranges from Rs 700-900 for Covishield manufactured by the Serum..
IndiaTimes
UK agreed to expand partnership on vaccines: MEA [Video]

UK agreed to expand partnership on vaccines: MEA

Prime Minister Narendra Modi held a virtual summit with his UK counterpart Boris Johnson on May 04. Speaking on the talks between the two leaders, MEA Joint Secretary (Europe West), Sandeep Chakraborty today said, "The two leaders (PM Modi and UK PM) also discussed the global pandemic situation and ongoing cooperation in the fight against it. PM Modi thanked PM Johnson for prompt medical assistance provided UK, in wake of severe 2nd wave in India." "UK was one of the first to respond, sending critical medical equipment, like oxygen concentrators, cylinders, ventilators, amongst others. The successful vaccine partnership through Oxford/AstraZeneca-SII collaboration was also discussed," he added.

Credit: ANI    Duration: 01:13Published

Adar Poonawalla Adar Poonawalla Indian businessman

Watch: Congress responds to Adar Poonawalla’s ‘being threatened’ charge [Video]

Watch: Congress responds to Adar Poonawalla’s ‘being threatened’ charge

Maharashtra Congress Chief chief Nana Patole has responded to SII chief Adar Poonawalla’s allegation that he is being threatened. Addressing the media, Patole said that Congress is worried over Poonawalla’s allegations and said that the Congress would take the responsibility of ensuring his security. He further urged Poonawalla to name those politicians who had threatened him over vaccine production. Poonawalla, who flew to London last week, is chief executive officer of the Serum Institute, which is the local maker of the coronavirus vaccine developed by Oxford University and pharmaceuticals company AstraZeneca. Watch the full video for all the details.

Credit: HT Digital Content    Duration: 02:05Published
Who threatened him?, asks Nana Patole on Adar Poonawalla's threat claims [Video]

Who threatened him?, asks Nana Patole on Adar Poonawalla's threat claims

During an interview to a London newspaper, head of Serum Institute of India (SII) Adar Poonawalla, who is one of the vaccine manufacturers in India, revealed that he is receiving threats from big leaders for early transportation of COVID-19 vaccine. While taking responsibility of his protection, Maharashtra Congress president Nana Patole during a press conference asked him to reveal the names of people who had threatened him. Nana Patole said, "No one will touch him in the country, he has to carry out the vaccine production in India in order to save the people of the country. Congress is with him and will take the onus of his protection. Who are these leaders? Who has threatened him? He should bring these things in limelight."

Credit: ANI    Duration: 01:36Published
‘Will return to India in a few days’: Adar Poonawalla after alleged threat calls [Video]

‘Will return to India in a few days’: Adar Poonawalla after alleged threat calls

Serum Institute of India CEO Adar Poonawalla, who has been in the UK on extended stay to evade alleged threats in India over ever-increasing demand for COVID-19 vaccines, has said he will return in a few days. In an interview to 'The Times', Poonawalla had alleged that he had been receiving threats in India and that he and his family had left the country for London after unprecedented "pressure and aggression" over the demand of COVID-19 vaccines. In a late night tweet on Saturday, he said the production of Covishield -- the Oxford/AstraZeneca's COVID-19 vaccine that is being produced by Serum Institute in India -- was in full swing at SII's facility in Pune. "Pleased to state that COVISHIELD's production is in full swing in Pune. I look forward to reviewing operations upon my return in a few days," Poonawalla said. Watch the full video for more details.

Credit: HT Digital Content    Duration: 01:50Published
‘Getting aggressive calls…’: Adar Poonawalla on Covid vaccine pressure in India [Video]

‘Getting aggressive calls…’: Adar Poonawalla on Covid vaccine pressure in India

Serum Institute of India CEO Adar Poonawalla on Saturday spoke out about the pressures he was under over the production of COVID-19 vaccines to meet the ever-increasing demand in India as the country battles through a devastating second wave of the coronavirus pandemic. In his first comments since he was provided with ‘Y’ category security by the Indian government earlier this week, Poonawalla told ‘The Times’ in an interview about receiving aggressive calls from some of the most powerful people in India, demanding supplies of Covishield -- the Oxford/AstraZeneca COVID-19 vaccine that the Serum Institute is producing in India. Watch the full video for more details.

Credit: HT Digital Content    Duration: 01:43Published

Related videos from verified sources

Covid-19: PM Modi interacts with 3 teams working on vaccine development [Video]

Covid-19: PM Modi interacts with 3 teams working on vaccine development

Prime Minister Narendra Modi interacted with three teams working on developing and manufacturing of vaccines against Covid-19. The teams were from Gennova Biopharmaceuticals Ltd, Biological E Ltd, and..

Credit: HT Digital Content     Duration: 01:15Published
Serum Institute of India faces legal notice, to file Rs.100 Cr case against volunteer|Oneindia News [Video]

Serum Institute of India faces legal notice, to file Rs.100 Cr case against volunteer|Oneindia News

After a Covidshield Coronavirus vaccine trial participant claimed that he suffered from a virtual neurological breakdown after being administered a dose, The Serum Institute of India has reacted..

Credit: Oneindia     Duration: 01:16Published
Covid-19 vaccine to be distributed initially in India says Serum Institute CEO [Video]

Covid-19 vaccine to be distributed initially in India says Serum Institute CEO

The CEO of India's Serum Institute says India will get supplies of the Oxford-AstraZeneca vaccine that his organisation produces, first.

Credit: Newsflare STUDIO     Duration: 01:28Published

Related news from verified sources

Markets zoom on hopes of Covid vaccine in India; banking stocks rise


newKerala.com Also reported by •Mid-DayZee News

'In dialogue with all vaccine manufacturers,' government on Pfizer's successful trial

The union health ministry revealed on Tuesday that the Centre is in dialogue with all vaccine manufacturers including foreign manufacturers about a Coronavirus...
Mid-Day Also reported by •IndiaTimes

Sputnik V vaccine can be produced in India, China: Vladimir Putin

Russian President Vladimir Putin on Tuesday called for a joint effort by the BRICS countries on the development of the coronavirus vaccines as he suggested that...
Mid-Day